Table 1 Summary of ARV treatment, lamin A/C, HPV and cervical lesions in CH and ME groups
CH group | ME group | ||||||
|---|---|---|---|---|---|---|---|
Lamin A/C (n = 86) | Women with HPVs | Cervical lesions | Years with ARV (y) | Lamin A/C | Women with HPVs | Cervical lesions | Years with ARV |
Normal N = 34 | 9 (10 %) | 0 | 1–13 years | Normal N = 35 | 5 (6 %) | 0 | No |
Low N = 22 | 7 (8 %) | 1 | 1–9 years | Low N = 21 | 3 (3 %) | 0 | No |
Absent N = 30 | 11 (13 %) | 3 | 1–15 years | absent N = 30 | 12 (14 %) | 1 | No |
Total N = 86 | 31 % | 5 | 1–15 years | N = 86 | 23 % | 1 | No |